Cozen O' Connor scored a 75 on the 2023 Corporate Equality Index (CEI) from the Human Rights Campaign (HRC), a political stakeholder group. By complying with the HRC’s controversial demands, Cozen O'Connor increases the risk of dividing employees, alienating customers and harming shareholders. The company covers transgender-related medical costs for its employees and their children and provides specific sexual orientation and gender identity-based benefits. It also uses sex and gender ideology criteria in vendor selection, marketing, and philanthropic support. Cozen O' Connor forces employees to undergo multiple ideological trainings and uses its reputation, corporate funds, and political influence to support controversial sex and gender ideologies, organizations, and legislation. The company provides a benefits package for employees which covers travel/lodging costs for an abortion and transgender medical procedures for covered employees and dependents, including children. Cozen O'Connor covers the cost of "medically necessary transition-related care” for its employees and their children. The company is Mansfield Certified, indicating its support of DEI in its recruitment, hiring, promotions, and leadership composition. Cozen O' Connor donated to the Equality PAC. The company is a partner of the Center for Reproductive Rights, building case law, advocating before policy makers, and engaging in litigation to challenge bans and restrictions on access to abortion. Cozen O' Connor is a member of The Diversity and Flexibility Alliance, indicating its support of DEI in its recruitment, retention, promotions, and leadership composition. The firm is a member of the MCCA, indicating its focus on recruiting, retaining, and promoting employees based on race. Cozen O' Connor is a part of the Law Firm Antiracism Alliance, committed to work on initiatives that fight “systemic racism”. However, the firm does not discriminate against charitable organizations based on views or beliefs. For these reasons, Cozen O'Connor receives a Medium Risk rating.